Cameron St Hilaire, MD
Vascular Surgery · Tarzana, CANPI 1386166361
Payments from drug & device makers
Across 55 payments — averaging $275.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Angiodynamics, Inc.$1K
- W. L. Gore & Associates, Inc.$977
- Koya Medical, Inc.$491
- Silk Road Medical, Inc.$362
- Surmodics, Inc.$164
- plus $638 from 10 others
What the payments were for
- Grants$10,06766%
- Food & beverage$3,64224%
- Other$1,44410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 13 | $11,077 |
| Angiodynamics, Inc. | 1 | $1,444 |
| W. L. Gore & Associates, Inc. | 20 | $977 |
| Koya Medical, Inc. | 1 | $491 |
| Silk Road Medical, Inc. | 4 | $362 |
| Surmodics, Inc. | 1 | $164 |
| Penumbra, Inc. | 1 | $146 |
| Boston Scientific | 1 | $137 |
| Dilon Technologies, Inc. | 2 | $77 |
| Stryker | 3 | $69 |
| Lemaitre Vascular, Inc. | 2 | $62 |
| Cvrx, Inc. | 2 | $48 |
| Mimedx Group, Inc. | 1 | $46 |
| Philips North America LLC | 1 | $24 |
| Argon Medical Devices, Inc. | 1 | $15 |
| Inspiremd Ltd | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$5,737
- Dayspring$1,472
- VenaCure 1470 Pro$1,444
- Koya Medical$491
- ENROUTE Transcarotid Neuroprotection System$488
- ENROUTE Transcarotid Stent$313
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$175
- Sublime 014 Rx PTA Balloon Dilatation Catheter$164
- Sublime Microcatheter, 018, 200cm, Straight$164
- Pounce Thrombectomy System$164
- Pounce Thrombectomy$164
- Pounce Venous Thrombectomy System$164
- GORE TAG Thoracic Branch Endoprosthesis$164
- CONCERTOTM$160
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$158
- Penumbra System$146
- GENERAL VASCULAR INTERVENTION$137
- GORE VIABAHN VBX Balloon Expandable Endo$136
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$126
How this compares
$15,153 in reported general payments places this provider in the 75th percentile of 519 vascular surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 14 | $193 |
| ClopidogrelClopidogrel Bisulfate | 27 | $151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $57 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Tarzana
- Venita ChandraPalo Alto$947K
- Leigh Ann ObanionFresno$932K
- Sukgu HanLos Angeles$765K
- Mahmoud Malasla Jolla$508K
- Son DuongFountain Valley$503K
- Leo FongClovis$496K
- Jason LeePalo Alto$403K
- Bernardo Curi MendesLos Angeles$376K
- Trevor DerderianRancho Mirage$359K
- Karthikeshwar KasirajanPalo Alto$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.